Solid Dosage
Cardiovascular medication
GEA provides proven solutions for manufacturing even the most challenging dosage forms of cardiovascular medication.
Manufacturing Cardiovascular Medication
There are many types and combinations of medicines available to treat coronary heart disease (CHD), high blood pressure or heart failure, including anticoagulants, antiplatelet medications, angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), beta blockers, calcium channel blockers, digoxin and diuretics.
Whatever the active ingredient, GEA provides proven solutions for even the most challenging dosage forms, such as MUPS tablets, effervescents and multi-layer dosage forms, as well as granules, pellets, modified/extended release formulations, powders designed for direct tableting or capsule filling and high-volume applications.
Still an important unit operation, coating is used to either add color, protect, mask the taste or create a modified release form in pharmaceutical production. GEA offers a range of standard, innovative, batch and continuous coater systems
Plus, as containment experts, the company offers the largest selection of solutions for contained processing based on a thorough containment risk analysis.
Providing increased yields, lower utility consumption and reduced waste, continuous manufacturing presents a new approach to high-volume oral dosage form production and meets the industry’s demands for faster product development, reduced costs, improved production economics and increased manufacturing flexibility.
Productos y tecnologías
Mostrar 4 de 26
Automatización del proceso
Como integradores de sistemas, unimos nuestro conocimiento sobre la tecnología de procesos y el diseño de plantas a los productos de software de los líderes del mercado.
Contained Materials Handling Systems
Contained Materials Handling solutions for Primary and Secondary Pharmaceuticals and Healthcare. With extensive experience within the generics sector, supply a wide range of technologies and equipment that improve and enhance the efficiency and performance of Oral Solid Dosage production.
Continuous Direct Compression Line
The ConsiGma® DC for direct compression is the latest expansion of GEA's continuous portfolio for cost effective, compact, high yield manufacturing systems. It offers a robust and flexible manufacturing method for a wide range of products.
Continuous Granulation Lines
Continuous Processing is becoming more and more important in the pharmaceutical industry. GEA takes the lead in introducing this innovative technology with ConsiGma® - continuous high-shear granulation and drying lines.
Downloads
GEA Insights
Alimentar el futuro: El poder de innovación de la liofilización
La reducción de residuos es importante para nosotros en GEA, y aprovechando el poder de la tecnología de liofilización, podemos transformar los excedentes de alimentos en productos valiosos y duraderos, ayudando a reducir sus residuos, prolongar la duración de almacenamiento y crear un suministro de alimentos más resistente para las generaciones venideras.
GEA y Pulmuone honran a generaciones de artesanos de la pasta fría
Cuando el productor surcoreano de alimentos de origen vegetal Pulmuone planteó a GEA el reto de desarrollar un giro moderno del tradicional fideo frío masticable (naengmyeon), los expertos en I+D de GEA estuvieron a la altura. Ayudaron a crear lo que ahora es un éxito comercial producido con menos agua y electricidad que los métodos antes existentes. El resultado también es fiel a los orígenes tradicionales del plato, así como a las raíces de salud, bienestar y sostenibilidad de Pulmuone.
